The article discusses ethical and legal aspects of the judgment of the Supreme Court of the United States (U.S.) on the patentability of human genes in trial occurred in June of 2013. Presents the background of the case as well, in general, places the current debate on human genetics patentability. The discussion reports on the judicial conflict developed in the U.S. under different and conflicting positions on the issue of patents, establishing commenting on the decision of the Court. Ahead of the facts and arguments conclude criticizes the judgment, showing that industrial property is at the center of negotiations on patent and pressure surpasses commercial interests to the same human values.
Ethics; Genetics; Products commerce-Genes; Judgment -United States; Legislation as topic-Commerce